Literature DB >> 21507967

Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance.

Serena A Carroll1, Jean-Marc Reynes, Marina L Khristova, Soa Fy Andriamandimby, Pierre E Rollin, Stuart T Nichol.   

Abstract

Rift Valley fever virus (RVFV), a mosquito-borne phlebovirus, has been detected in Madagascar since 1979, with occasional outbreaks. In 2008 to 2009, a large RVFV outbreak was detected in Malagasy livestock and humans during two successive rainy seasons. To determine whether cases were due to enzootic maintenance of the virus within Madagascar or to importation from the East African mainland, nine RVFV whole genomic sequences were generated for viruses from the 1991 and 2008 Malagasy outbreaks. Bayesian coalescent analyses of available whole S, M, and L segment sequences were used to estimate the time to the most recent common ancestor for the RVFVs. The 1979 Madagascar isolate shared a common ancestor with strains on the mainland around 1972. The 1991 Madagascar isolates were in a clade distinct from that of the 1979 isolate and shared a common ancestor around 1987. Finally, the 2008 Madagascar viruses were embedded within a large clade of RVFVs from the 2006-2007 outbreak in East Africa and shared a common ancestor around 2003 to 2004. These results suggest that the most recent Madagascar outbreak was caused by a virus likely arriving in the country some time between 2003 and 2008 and that this outbreak may be an extension of the 2006-2007 East African outbreak. Clustering of the Malagasy sequences into subclades indicates that the viruses have continued to evolve during their short-term circulation within the country. These data are consistent with the notion that RVFV outbreaks in Madagascar result not from emergence from enzootic cycles within the country but from recurrent virus introductions from the East African mainland.

Entities:  

Mesh:

Year:  2011        PMID: 21507967      PMCID: PMC3126502          DOI: 10.1128/JVI.00335-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya.

Authors:  K J Linthicum; A Anyamba; C J Tucker; P W Kelley; M F Myers; C J Peters
Journal:  Science       Date:  1999-07-16       Impact factor: 47.728

2.  Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry.

Authors:  Brian H Bird; Marina L Khristova; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

3.  Outbreaks of Rift Valley fever in Kenya, Somalia and United Republic of Tanzania, December 2006-April 2007.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-05-18

4.  Prediction of a Rift Valley fever outbreak.

Authors:  Assaf Anyamba; Jean-Paul Chretien; Jennifer Small; Compton J Tucker; Pierre B Formenty; Jason H Richardson; Seth C Britch; David C Schnabel; Ralph L Erickson; Kenneth J Linthicum
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-14       Impact factor: 11.205

5.  An outbreak of East Coast Fever on the Comoros: a consequence of the import of immunised cattle from Tanzania?

Authors:  R De Deken; V Martin; A Saido; M Madder; J Brandt; D Geysen
Journal:  Vet Parasitol       Date:  2006-09-25       Impact factor: 2.738

6.  Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007.

Authors:  Brian H Bird; Jane W K Githinji; Joseph M Macharia; Jacqueline L Kasiiti; Rees M Muriithi; Stephen G Gacheru; Joseph O Musaa; Jonathan S Towner; Serena A Reeder; Jennifer B Oliver; Thomas L Stevens; Bobbie R Erickson; Laura T Morgan; Marina L Khristova; Amy L Hartman; James A Comer; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

7.  Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004.

Authors:  Kibet Sergon; Charles Njuguna; Rosalia Kalani; Victor Ofula; Clayton Onyango; Limbaso S Konongoi; Sheryl Bedno; Heather Burke; Athman M Dumilla; Joseph Konde; M Kariuki Njenga; Rosemary Sang; Robert F Breiman
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

8.  Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak.

Authors:  Isabelle Schuffenecker; Isabelle Iteman; Alain Michault; Séverine Murri; Lionel Frangeul; Marie-Christine Vaney; Rachel Lavenir; Nathalie Pardigon; Jean-Marc Reynes; François Pettinelli; Leon Biscornet; Laure Diancourt; Stéphanie Michel; Stéphane Duquerroy; Ghislaine Guigon; Marie-Pascale Frenkiel; Anne-Claire Bréhin; Nadège Cubito; Philippe Desprès; Frank Kunst; Félix A Rey; Hervé Zeller; Sylvain Brisse
Journal:  PLoS Med       Date:  2006-05-23       Impact factor: 11.069

9.  BEAST: Bayesian evolutionary analysis by sampling trees.

Authors:  Alexei J Drummond; Andrew Rambaut
Journal:  BMC Evol Biol       Date:  2007-11-08       Impact factor: 3.260

10.  MAFFT version 5: improvement in accuracy of multiple sequence alignment.

Authors:  Kazutaka Katoh; Kei-ichi Kuma; Hiroyuki Toh; Takashi Miyata
Journal:  Nucleic Acids Res       Date:  2005-01-20       Impact factor: 16.971

View more
  32 in total

1.  A 3-year serological and virological cattle follow-up in Madagascar highlands suggests a non-classical transmission route of Rift Valley fever virus.

Authors:  Gaëlle Nicolas; Benoit Durand; Tafika Tojofaniry Rakotoarimanana; Sandra Lacote; Véronique Chevalier; Philippe Marianneau
Journal:  Am J Trop Med Hyg       Date:  2013-12-23       Impact factor: 2.345

Review 2.  A review of mosquitoes associated with Rift Valley fever virus in Madagascar.

Authors:  Luciano M Tantely; Sébastien Boyer; Didier Fontenille
Journal:  Am J Trop Med Hyg       Date:  2015-03-02       Impact factor: 2.345

3.  Seroprevalence of Rift Valley fever virus in cattle in the Democratic Republic of the Congo.

Authors:  Georges Mbuyi Tshilenge; William G Dundon; Marco De Nardi; Leopold K Mulumba Mfumu; Mark Rweyemamu; Jean-Marie Kayembe-Ntumba; Justin Masumu
Journal:  Trop Anim Health Prod       Date:  2018-10-22       Impact factor: 1.559

4.  Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.

Authors:  Tetsuro Ikegami; Terence E Hill; Jennifer K Smith; Lihong Zhang; Terry L Juelich; Bin Gong; Olga A L Slack; Hoai J Ly; Nandadeva Lokugamage; Alexander N Freiberg
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

5.  Heparan sulfate facilitates Rift Valley fever virus entry into the cell.

Authors:  S M de Boer; J Kortekaas; C A M de Haan; P J M Rottier; R J M Moormann; B J Bosch
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

Review 6.  Molecular biology and genetic diversity of Rift Valley fever virus.

Authors:  Tetsuro Ikegami
Journal:  Antiviral Res       Date:  2012-06-16       Impact factor: 5.970

7.  Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.

Authors:  Brian H Bird; Louis H Maartens; Shelley Campbell; Baltus J Erasmus; Bobbie R Erickson; Kimberly A Dodd; Christina F Spiropoulou; Deborah Cannon; Clifton P Drew; Barbara Knust; Anita K McElroy; Marina L Khristova; César G Albariño; Stuart T Nichol
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

8.  RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge.

Authors:  Megan E Ermler; Ekaterina Yerukhim; Jill Schriewer; Stefan Schattgen; Zachary Traylor; Adam R Wespiser; Daniel R Caffrey; Zhijian J Chen; Charles H King; Michael Gale; Marco Colonna; Katherine A Fitzgerald; R Mark L Buller; Amy G Hise
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

9.  Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.

Authors:  Hoai J Ly; Shoko Nishiyama; Nandadeva Lokugamage; Jennifer K Smith; Lihong Zhang; David Perez; Terry L Juelich; Alexander N Freiberg; Tetsuro Ikegami
Journal:  Vaccine       Date:  2017-10-20       Impact factor: 3.641

10.  The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine.

Authors:  Olga Lihoradova; Birte Kalveram; Sabarish V Indran; Nandadeva Lokugamage; Terry L Juelich; Terence E Hill; Chien-Te K Tseng; Bin Gong; Shuetsu Fukushi; Shigeru Morikawa; Alexander N Freiberg; Tetsuro Ikegami
Journal:  J Virol       Date:  2012-05-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.